effects [qlco]
Oral [spco]
Hormone replacement therapy [topp]
Mean Platelet Volume [lbpr]
postmenopausal [tmco]
Women [popg]
effects [qlco]
Hormone replacement therapy [topp]
Mean Platelet Volume [lbpr]
Lipid [lipd]
Profile [lbpr]
C-reactive protein level [lbpr]
postmenopausal [tmco]
Women [popg]
High Risk [qlco]
Cardiovascular disease [dsyn]
Materials [sbst]
Methods [inpr]
Study [mnob]
Performed [ftcn]
twenty [orch, phsu]
Seven [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Received [qlco]
mg% [qnco]
Estradiol [horm, phsu, strd]
mg% [qnco]
drospirenone [orch, phsu]
Orally [spco]
months [tmco]
twenty [orch, phsu]
Eight [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Take [hlca]
Hormone replacement therapy [topp]
admitted [hlca]
Study [mnob]
control population [ocdi]
Independent [idcn]
Group [idcn]
statistically significant [qnco]
Mean Platelet Volume [lbpr]
Variable [qlco]
P NOS [aapp, imft]
Mean Platelet Volume [lbpr]
Levels [qlco]
Cardiovascular disease [dsyn]
Markers, Risk [qlco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Compared [acty]
Women [popg]
Control Group [grup]
Young [tmco]
postmenopausal [tmco]
Women [popg]
Take [hlca]
Hormone replacement therapy [topp]
Women [popg]
Initiate [idcn]
Hormone Therapy [topp]
Close [ftcn]
Menopause [phsf]
Increased [qnco]
Cardiovascular disease [dsyn]
